Ultrasound-Guided  ||| S:0 E:18 ||| NNP
Versus  ||| S:18 E:25 ||| NNP
Blind  ||| S:25 E:31 ||| NNP
Subacromial  ||| S:31 E:43 ||| NNP
Corticosteroid  ||| S:43 E:58 ||| NNP
Injections  ||| S:58 E:69 ||| NNP
for  ||| S:69 E:73 ||| IN
Subacromial  ||| S:73 E:85 ||| NNP
Impingement  ||| S:85 E:97 ||| NNP
Syndrome ||| S:97 E:105 ||| NNP
:  ||| S:105 E:107 ||| :
A  ||| S:107 E:109 ||| DT
Randomized ||| S:109 E:119 ||| NNP
,  ||| S:119 E:121 ||| ,
Double-Blind  ||| S:121 E:134 ||| NNP
Clinical  ||| S:134 E:143 ||| NNP
Trial  ||| S:143 E:149 ||| NNP
Subacromial  ||| S:149 E:161 ||| NNP
corticosteroid  ||| S:161 E:176 ||| NN
injections  ||| S:176 E:187 ||| NNS
are  ||| S:187 E:191 ||| VBP
frequently  ||| S:191 E:202 ||| RB
performed  ||| S:202 E:212 ||| VBN
for  ||| S:212 E:216 ||| IN
impingement  ||| S:216 E:228 ||| JJ
syndrome  ||| S:228 E:237 ||| NN
of  ||| S:237 E:240 ||| IN
the  ||| S:240 E:244 ||| DT
shoulder ||| S:244 E:252 ||| NN
.  ||| S:252 E:254 ||| .
To  ||| S:254 E:257 ||| TO
improve  ||| S:257 E:265 ||| VB
the  ||| S:265 E:269 ||| DT
accuracy  ||| S:269 E:278 ||| NN
of  ||| S:278 E:281 ||| IN
injections ||| S:281 E:291 ||| NNS
,  ||| S:291 E:293 ||| ,
ultrasound  ||| S:293 E:304 ||| NN
can  ||| S:304 E:308 ||| MD
be  ||| S:308 E:311 ||| VB
used ||| S:311 E:315 ||| VBN
.  ||| S:315 E:317 ||| .
To  ||| S:317 E:320 ||| TO
assess  ||| S:320 E:327 ||| VB
the  ||| S:327 E:331 ||| DT
clinical  ||| S:331 E:340 ||| JJ
outcome  ||| S:340 E:348 ||| NN
of  ||| S:348 E:351 ||| IN
ultrasound-guided  ||| S:351 E:369 ||| JJ
subacromial  ||| S:369 E:381 ||| NNS
injections  ||| S:381 E:392 ||| VBP
compared  ||| S:392 E:401 ||| VBN
with  ||| S:401 E:406 ||| IN
blind  ||| S:406 E:412 ||| JJ
subacromial  ||| S:412 E:424 ||| JJ
injections  ||| S:424 E:435 ||| NNS
for  ||| S:435 E:439 ||| IN
subacromial  ||| S:439 E:451 ||| JJ
impingement  ||| S:451 E:463 ||| JJ
syndrome ||| S:463 E:471 ||| NN
.  ||| S:471 E:473 ||| .
Randomized  ||| S:473 E:484 ||| NNP
controlled  ||| S:484 E:495 ||| VBD
clinical  ||| S:495 E:504 ||| JJ
trial ||| S:504 E:509 ||| NN
;  ||| S:509 E:511 ||| :
Level  ||| S:511 E:517 ||| NNP
of  ||| S:517 E:520 ||| IN
evidence ||| S:520 E:528 ||| NN
,  ||| S:528 E:530 ||| ,
1 ||| S:530 E:531 ||| CD
.  ||| S:531 E:533 ||| .
A  ||| S:533 E:535 ||| DT
total  ||| S:535 E:541 ||| NN
of  ||| S:541 E:544 ||| IN
56  ||| S:544 E:547 ||| CD
shoulders  ||| S:547 E:557 ||| NNS
with  ||| S:557 E:562 ||| IN
subacromial  ||| S:562 E:574 ||| JJ
impingement  ||| S:574 E:586 ||| JJ
syndrome  ||| S:586 E:595 ||| NN
were  ||| S:595 E:600 ||| VBD
randomized  ||| S:600 E:611 ||| VBN
into  ||| S:611 E:616 ||| IN
2  ||| S:616 E:618 ||| CD
groups ||| S:618 E:624 ||| NNS
:  ||| S:624 E:626 ||| :
28  ||| S:626 E:629 ||| CD
shoulders  ||| S:629 E:639 ||| NNS
received  ||| S:639 E:648 ||| VBD
a  ||| S:648 E:650 ||| DT
subacromial  ||| S:650 E:662 ||| JJ
corticosteroid  ||| S:662 E:677 ||| JJ
injection  ||| S:677 E:687 ||| NN
with  ||| S:687 E:692 ||| IN
ultrasound  ||| S:692 E:703 ||| JJ
guidance  ||| S:703 E:712 ||| NN
( ||| S:712 E:713 ||| -LRB-
ultrasound  ||| S:713 E:724 ||| JJ
group ||| S:724 E:729 ||| NN
) ||| S:729 E:730 ||| -RRB-
,  ||| S:730 E:732 ||| ,
and  ||| S:732 E:736 ||| CC
28  ||| S:736 E:739 ||| CD
shoulders  ||| S:739 E:749 ||| NNS
received  ||| S:749 E:758 ||| VBD
a  ||| S:758 E:760 ||| DT
subacromial  ||| S:760 E:772 ||| JJ
corticosteroid  ||| S:772 E:787 ||| JJ
injection  ||| S:787 E:797 ||| NN
without  ||| S:797 E:805 ||| IN
ultrasound  ||| S:805 E:816 ||| JJ
guidance  ||| S:816 E:825 ||| NN
( ||| S:825 E:826 ||| -LRB-
blind  ||| S:826 E:832 ||| JJ
group ||| S:832 E:837 ||| NN
) ||| S:837 E:838 ||| -RRB-
.  ||| S:838 E:840 ||| .
The  ||| S:840 E:844 ||| DT
visual  ||| S:844 E:851 ||| JJ
analog  ||| S:851 E:858 ||| JJ
scale  ||| S:858 E:864 ||| NN
( ||| S:864 E:865 ||| -LRB-
VAS ||| S:865 E:868 ||| NNP
)  ||| S:868 E:870 ||| -RRB-
for  ||| S:870 E:874 ||| IN
pain  ||| S:874 E:879 ||| NN
with  ||| S:879 E:884 ||| IN
overhead  ||| S:884 E:893 ||| JJ
activities  ||| S:893 E:904 ||| NNS
and  ||| S:904 E:908 ||| CC
the  ||| S:908 E:912 ||| DT
American  ||| S:912 E:921 ||| NNP
Shoulder  ||| S:921 E:930 ||| NNP
and  ||| S:930 E:934 ||| CC
Elbow  ||| S:934 E:940 ||| NNP
Surgeons  ||| S:940 E:949 ||| NNP
( ||| S:949 E:950 ||| -LRB-
ASES ||| S:950 E:954 ||| NNP
)  ||| S:954 E:956 ||| -RRB-
score  ||| S:956 E:962 ||| NN
were  ||| S:962 E:967 ||| VBD
obtained  ||| S:967 E:976 ||| VBN
before  ||| S:976 E:983 ||| IN
the  ||| S:983 E:987 ||| DT
injection  ||| S:987 E:997 ||| NN
and  ||| S:997 E:1001 ||| CC
at  ||| S:1001 E:1004 ||| IN
6  ||| S:1004 E:1006 ||| CD
weeks  ||| S:1006 E:1012 ||| NNS
after  ||| S:1012 E:1018 ||| IN
the  ||| S:1018 E:1022 ||| DT
injection ||| S:1022 E:1031 ||| NN
.  ||| S:1031 E:1033 ||| .
The  ||| S:1033 E:1037 ||| DT
VAS  ||| S:1037 E:1041 ||| NNP
score  ||| S:1041 E:1047 ||| NN
for  ||| S:1047 E:1051 ||| IN
pain  ||| S:1051 E:1056 ||| NN
with  ||| S:1056 E:1061 ||| IN
overhead  ||| S:1061 E:1070 ||| JJ
activities  ||| S:1070 E:1081 ||| NNS
decreased  ||| S:1081 E:1091 ||| VBD
from  ||| S:1091 E:1096 ||| IN
59  ||| S:1096 E:1099 ||| CD
±  ||| S:1099 E:1101 ||| CD
5  ||| S:1101 E:1103 ||| CD
mm  ||| S:1103 E:1106 ||| NNS
( ||| S:1106 E:1107 ||| -LRB-
mean  ||| S:1107 E:1112 ||| VB
±  ||| S:1112 E:1114 ||| NNP
SEM ||| S:1114 E:1117 ||| NNP
)  ||| S:1117 E:1119 ||| -RRB-
before  ||| S:1119 E:1126 ||| IN
the  ||| S:1126 E:1130 ||| DT
injection  ||| S:1130 E:1140 ||| NN
to  ||| S:1140 E:1143 ||| TO
33  ||| S:1143 E:1146 ||| CD
±  ||| S:1146 E:1148 ||| CD
6  ||| S:1148 E:1150 ||| CD
mm  ||| S:1150 E:1153 ||| NN
at  ||| S:1153 E:1156 ||| IN
6  ||| S:1156 E:1158 ||| CD
weeks  ||| S:1158 E:1164 ||| NNS
after  ||| S:1164 E:1170 ||| IN
the  ||| S:1170 E:1174 ||| DT
injection  ||| S:1174 E:1184 ||| NN
in  ||| S:1184 E:1187 ||| IN
the  ||| S:1187 E:1191 ||| DT
ultrasound  ||| S:1191 E:1202 ||| NN
group  ||| S:1202 E:1208 ||| NN
( ||| S:1208 E:1209 ||| -LRB-
P  ||| S:1209 E:1211 ||| NNP
< ||| S:1211 E:1213 ||| SYM
.001 ||| S:1213 E:1217 ||| NNP
)  ||| S:1217 E:1219 ||| -RRB-
and  ||| S:1219 E:1223 ||| CC
from  ||| S:1223 E:1228 ||| IN
63  ||| S:1228 E:1231 ||| CD
±  ||| S:1231 E:1233 ||| CD
4  ||| S:1233 E:1235 ||| CD
mm  ||| S:1235 E:1238 ||| NN
to  ||| S:1238 E:1241 ||| TO
39  ||| S:1241 E:1244 ||| CD
±  ||| S:1244 E:1246 ||| CD
6  ||| S:1246 E:1248 ||| CD
mm ||| S:1248 E:1250 ||| NN
,  ||| S:1250 E:1252 ||| ,
respectively ||| S:1252 E:1264 ||| RB
,  ||| S:1264 E:1266 ||| ,
in  ||| S:1266 E:1269 ||| IN
the  ||| S:1269 E:1273 ||| DT
blind  ||| S:1273 E:1279 ||| JJ
group  ||| S:1279 E:1285 ||| NN
( ||| S:1285 E:1286 ||| -LRB-
P  ||| S:1286 E:1288 ||| NNP
< ||| S:1288 E:1290 ||| SYM
.001 ||| S:1290 E:1294 ||| NNP
) ||| S:1294 E:1295 ||| -RRB-
.  ||| S:1295 E:1297 ||| .
The  ||| S:1297 E:1301 ||| DT
decrease  ||| S:1301 E:1310 ||| NN
in  ||| S:1310 E:1313 ||| IN
the  ||| S:1313 E:1317 ||| DT
VAS  ||| S:1317 E:1321 ||| NNP
score  ||| S:1321 E:1327 ||| NN
was  ||| S:1327 E:1331 ||| VBD
not  ||| S:1331 E:1335 ||| RB
significantly  ||| S:1335 E:1349 ||| RB
different  ||| S:1349 E:1359 ||| JJ
between  ||| S:1359 E:1367 ||| IN
the  ||| S:1367 E:1371 ||| DT
groups  ||| S:1371 E:1378 ||| NNS
( ||| S:1378 E:1379 ||| -LRB-
P  ||| S:1379 E:1381 ||| NNP
>  ||| S:1381 E:1383 ||| NNP
.999 ||| S:1383 E:1387 ||| NNP
) ||| S:1387 E:1388 ||| -RRB-
.  ||| S:1388 E:1390 ||| .
The  ||| S:1390 E:1394 ||| DT
ASES  ||| S:1394 E:1399 ||| NNP
score  ||| S:1399 E:1405 ||| VBP
increased  ||| S:1405 E:1415 ||| VBN
from  ||| S:1415 E:1420 ||| IN
57  ||| S:1420 E:1423 ||| CD
±  ||| S:1423 E:1425 ||| CD
2  ||| S:1425 E:1427 ||| CD
before  ||| S:1427 E:1434 ||| IN
the  ||| S:1434 E:1438 ||| DT
injection  ||| S:1438 E:1448 ||| NN
to  ||| S:1448 E:1451 ||| TO
68  ||| S:1451 E:1454 ||| CD
±  ||| S:1454 E:1456 ||| CD
3  ||| S:1456 E:1458 ||| CD
at  ||| S:1458 E:1461 ||| IN
6  ||| S:1461 E:1463 ||| CD
weeks  ||| S:1463 E:1469 ||| NNS
after  ||| S:1469 E:1475 ||| IN
the  ||| S:1475 E:1479 ||| DT
injection  ||| S:1479 E:1489 ||| NN
in  ||| S:1489 E:1492 ||| IN
the  ||| S:1492 E:1496 ||| DT
ultrasound  ||| S:1496 E:1507 ||| NN
group  ||| S:1507 E:1513 ||| NN
( ||| S:1513 E:1514 ||| -LRB-
P  ||| S:1514 E:1516 ||| NNP
< ||| S:1516 E:1518 ||| SYM
.01 ||| S:1518 E:1521 ||| NNP
)  ||| S:1521 E:1523 ||| -RRB-
and  ||| S:1523 E:1527 ||| CC
from  ||| S:1527 E:1532 ||| IN
54  ||| S:1532 E:1535 ||| CD
±  ||| S:1535 E:1537 ||| CD
3  ||| S:1537 E:1539 ||| CD
before  ||| S:1539 E:1546 ||| IN
the  ||| S:1546 E:1550 ||| DT
injection  ||| S:1550 E:1560 ||| NN
to  ||| S:1560 E:1563 ||| TO
65  ||| S:1563 E:1566 ||| CD
±  ||| S:1566 E:1568 ||| CD
4  ||| S:1568 E:1570 ||| CD
after  ||| S:1570 E:1576 ||| IN
the  ||| S:1576 E:1580 ||| DT
injection  ||| S:1580 E:1590 ||| NN
in  ||| S:1590 E:1593 ||| IN
the  ||| S:1593 E:1597 ||| DT
blind  ||| S:1597 E:1603 ||| JJ
group  ||| S:1603 E:1609 ||| NN
( ||| S:1609 E:1610 ||| -LRB-
P  ||| S:1610 E:1612 ||| NNP
< ||| S:1612 E:1614 ||| SYM
.01 ||| S:1614 E:1617 ||| NNP
) ||| S:1617 E:1618 ||| -RRB-
,  ||| S:1618 E:1620 ||| ,
with  ||| S:1620 E:1625 ||| IN
no  ||| S:1625 E:1628 ||| DT
significant  ||| S:1628 E:1640 ||| JJ
difference  ||| S:1640 E:1651 ||| NN
between  ||| S:1651 E:1659 ||| IN
the  ||| S:1659 E:1663 ||| DT
groups  ||| S:1663 E:1670 ||| NNS
( ||| S:1670 E:1671 ||| -LRB-
P  ||| S:1671 E:1673 ||| NN
=  ||| S:1673 E:1675 ||| SYM
.7 ||| S:1675 E:1677 ||| CD
) ||| S:1677 E:1678 ||| -RRB-
.  ||| S:1678 E:1680 ||| .
Four  ||| S:1680 E:1685 ||| CD
shoulders  ||| S:1685 E:1695 ||| NNS
( ||| S:1695 E:1696 ||| -LRB-
14 ||| S:1696 E:1698 ||| CD
% ||| S:1698 E:1699 ||| NN
)  ||| S:1699 E:1701 ||| -RRB-
in  ||| S:1701 E:1704 ||| IN
the  ||| S:1704 E:1708 ||| DT
ultrasound  ||| S:1708 E:1719 ||| NN
group  ||| S:1719 E:1725 ||| NN
and  ||| S:1725 E:1729 ||| CC
6  ||| S:1729 E:1731 ||| CD
shoulders  ||| S:1731 E:1741 ||| NNS
( ||| S:1741 E:1742 ||| -LRB-
21 ||| S:1742 E:1744 ||| CD
% ||| S:1744 E:1745 ||| NN
)  ||| S:1745 E:1747 ||| -RRB-
in  ||| S:1747 E:1750 ||| IN
the  ||| S:1750 E:1754 ||| DT
blind  ||| S:1754 E:1760 ||| JJ
group  ||| S:1760 E:1766 ||| NN
eventually  ||| S:1766 E:1777 ||| RB
needed  ||| S:1777 E:1784 ||| VBN
surgery  ||| S:1784 E:1792 ||| NN
( ||| S:1792 E:1793 ||| -LRB-
P  ||| S:1793 E:1795 ||| NN
=  ||| S:1795 E:1797 ||| SYM
.7 ||| S:1797 E:1799 ||| CD
) ||| S:1799 E:1800 ||| -RRB-
.  ||| S:1800 E:1802 ||| .
No  ||| S:1802 E:1805 ||| DT
significant  ||| S:1805 E:1817 ||| JJ
differences  ||| S:1817 E:1829 ||| NNS
were  ||| S:1829 E:1834 ||| VBD
found  ||| S:1834 E:1840 ||| VBN
in  ||| S:1840 E:1843 ||| IN
the  ||| S:1843 E:1847 ||| DT
clinical  ||| S:1847 E:1856 ||| JJ
outcome  ||| S:1856 E:1864 ||| NN
when  ||| S:1864 E:1869 ||| WRB
comparing  ||| S:1869 E:1879 ||| VBG
ultrasound-guided  ||| S:1879 E:1897 ||| JJ
subacromial  ||| S:1897 E:1909 ||| JJ
injections  ||| S:1909 E:1920 ||| NNS
to  ||| S:1920 E:1923 ||| TO
blind  ||| S:1923 E:1929 ||| VB
subacromial  ||| S:1929 E:1941 ||| JJ
injections  ||| S:1941 E:1952 ||| NNS
for  ||| S:1952 E:1956 ||| IN
subacromial  ||| S:1956 E:1968 ||| JJ
impingement  ||| S:1968 E:1980 ||| JJ
syndrome ||| S:1980 E:1988 ||| NN
.  ||| S:1988 E:1990 ||| .
Australian  ||| S:1990 E:2001 ||| NNP
New  ||| S:2001 E:2005 ||| NNP
Zealand  ||| S:2005 E:2013 ||| NNP
Clinical  ||| S:2013 E:2022 ||| NNP
Trials  ||| S:2022 E:2029 ||| NNP
Registry ||| S:2029 E:2037 ||| NNP
:  ||| S:2037 E:2039 ||| :
ACTRN12615000562572 ||| S:2039 E:2058 ||| CD
.  ||| S:2058 E:2060 ||| .
